Regarding medications, 83% of the total CHF population were being treated with an angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB), and 80% received β-blockers; 9% of the diabetic patients with CHF were treated with insulin. This evidence concerns the gene INS and congestive heart failure.